JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,104,000 | +756734.5% | 1,136,847 | +354.4% | 0.00% | – |
| Q4 2022 | $278 | -100.0% | 250,208 | +0.1% | 0.00% | – |
| Q3 2022 | $585,000 | -25.9% | 250,067 | -4.0% | 0.00% | – |
| Q2 2022 | $790,000 | -48.2% | 260,570 | +16.1% | 0.00% | – |
| Q1 2022 | $1,524,000 | -30.8% | 224,384 | -15.0% | 0.00% | – |
| Q4 2021 | $2,203,000 | +1.4% | 263,893 | -9.8% | 0.00% | – |
| Q3 2021 | $2,173,000 | -3.2% | 292,425 | -11.5% | 0.00% | – |
| Q2 2021 | $2,245,000 | +32.2% | 330,303 | +99.9% | 0.00% | – |
| Q1 2021 | $1,698,000 | +99.1% | 165,275 | +35.7% | 0.00% | – |
| Q4 2020 | $853,000 | -17.5% | 121,789 | -3.2% | 0.00% | – |
| Q3 2020 | $1,034,000 | +10.6% | 125,807 | -7.1% | 0.00% | – |
| Q2 2020 | $935,000 | +30.6% | 135,397 | -10.2% | 0.00% | – |
| Q1 2020 | $716,000 | -53.1% | 150,738 | -13.8% | 0.00% | – |
| Q4 2019 | $1,527,000 | +27.0% | 174,937 | -51.5% | 0.00% | – |
| Q3 2019 | $1,202,000 | -13.2% | 360,765 | +22.1% | 0.00% | – |
| Q2 2019 | $1,384,000 | -20.4% | 295,568 | +5.4% | 0.00% | – |
| Q1 2019 | $1,739,000 | -16.8% | 280,443 | -54.8% | 0.00% | – |
| Q4 2018 | $2,091,000 | -26.9% | 620,148 | +40.9% | 0.00% | -100.0% |
| Q3 2018 | $2,861,000 | +114.8% | 440,029 | +153.0% | 0.00% | – |
| Q2 2018 | $1,332,000 | -60.6% | 173,903 | +14.9% | 0.00% | -100.0% |
| Q1 2018 | $3,384,000 | +63.2% | 151,415 | -6.9% | 0.00% | – |
| Q4 2017 | $2,074,000 | +219.6% | 162,723 | +285.6% | 0.00% | – |
| Q3 2017 | $649,000 | +7.8% | 42,200 | -1.6% | 0.00% | – |
| Q2 2017 | $602,000 | -74.4% | 42,900 | -59.9% | 0.00% | -100.0% |
| Q1 2017 | $2,354,000 | – | 107,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |